Recommended Topic Related To:

Malarone

"A unique type of poster placed in exam rooms helped reduce unnecessary antibiotic prescriptions for respiratory infections during flu season. The approach could help reduce costs and extend the usefulness of these drugs.

Antibiotics a"...

Malarone

Malarone

INDICATIONS

Prevention of Malaria

MALARONE® is indicated for the prophylaxis of Plasmodium falciparum malaria, including in areas where chloroquine resistance has been reported.

Treatment of Malaria

MALARONE is indicated for the treatment of acute, uncomplicated P. falciparum malaria. MALARONE has been shown to be effective in regions where the drugs chloroquine, halofantrine, mefloquine, and amodiaquine may have unacceptable failure rates, presumably due to drug resistance.

DOSAGE AND ADMINISTRATION

The daily dose should be taken at the same time each day with food or a milky drink. In the event of vomiting within 1 hour after dosing, a repeat dose should be taken.

MALARONE may be crushed and mixed with condensed milk just prior to administration to patients who may have difficulty swallowing tablets.

Prevention of Malaria

Start prophylactic treatment with MALARONE 1 or 2 days before entering a malaria-endemic area and continue daily during the stay and for 7 days after return.

Adults: One MALARONE Tablet (adult strength = 250 mg atovaquone/100 mg proguanil hydrochloride) per day.

Pediatric Patients: The dosage for prevention of malaria in pediatric patients is based upon body weight (Table 1).

Table 1: Dosage for Prevention of Malaria in Pediatric Patients

Weight (kg) Atovaquone/ Proguanil HCl Total Daily Dose Dosage Regimen
11-20 62.5 mg/25 mg 1 MALARONE Pediatric Tablet daily
21-30 125 mg/50 mg 2 MALARONE Pediatric Tablets as a single daily dose
31-40 187.5 mg/75 mg 3 MALARONE Pediatric Tablets as a single daily dose
> 40 250 mg/100 mg 1 MALARONE Tablet (adult strength) as a single daily dose

Treatment of Acute Malaria

Adults: Four MALARONE Tablets (adult strength; total daily dose 1 g atovaquone/400 mg proguanil hydrochloride) as a single daily dose for 3 consecutive days.

Pediatric Patients: The dosage for treatment of acute malaria in pediatric patients is based upon body weight (Table 2).

Table 2: Dosage for Treatment of Acute Malaria in Pediatric Patients

Weight (kg) Atovaquone/ Proguanil HCl Total Daily Dose Dosage Regimen
5-8 125 mg/50 mg 2 MALARONE Pediatric Tablets daily for 3 consecutive days
9-10 187.5 mg/75 mg 3 MALARONE Pediatric Tablets daily for 3 consecutive days
11-20 250 mg/100 mg 1 MALARONE Tablet (adult strength) daily for 3 consecutive days
21-30 500 mg/200 mg 2 MALARONE Tablets (adult strength) as a single daily dose for 3 consecutive days
31-40 750 mg/300 mg 3 MALARONE Tablets (adult strength) as a single daily dose for 3 consecutive days
> 40 1 g/400 mg 4 MALARONE Tablets (adult strength) as a single daily dose for 3 consecutive days

Renal Impairment

Do not use MALARONE for malaria prophylaxis in patients with severe renal impairment (creatinine clearance < 30 mL/min) [See CONTRAINDICATIONS]. Use with caution for the treatment of malaria in patients with severe renal impairment, only if the benefits of the 3 day treatment regimen outweigh the potential risks associated with increased drug exposure. No dosage adjustments are needed in patients with mild (creatinine clearance 50 to 80 mL/min) or moderate (creatinine clearance 30 to 50 mL/min) renal impairment. [See CLINICAL PHARMACOLOGY.]

HOW SUPPLIED

Dosage Forms And Strengths

Each MALARONE Tablet (adult strength) contains 250 mg atovaquone and 100 mg proguanil hydrochloride. MALARONE Tablets are pink, film-coated, round, biconvex tablets engraved with “GX CM3” on one side.

Each MALARONE Pediatric Tablet contains 62.5 mg atovaquone and 25 mg proguanil hydrochloride. MALARONE Pediatric Tablets are pink, film-coated, round, biconvex tablets engraved with “GX CG7” on one side.

Storage And Handling

MALARONE Tablets, containing 250 mg atovaquone and 100 mg proguanil hydrochloride.

Bottle of 100 tablets with child-resistant closure (NDC 0173-0675-01).
Unit Dose Pack of 24 (NDC 0173-0675-02).

MALARONE Pediatric Tablets, containing 62.5 mg atovaquone and 25 mg proguanil hydrochloride.

Bottle of 100 tablets with child-resistant closure (NDC 0173-0676-01).

Storage Conditions

Store at 25°C (77°F). Temperature excursions are permitted to 15° to 30°C (59° to 86°F) (see USP Controlled Room Temperature).

GlaxoSmithKline Research Triangle Park, NC 27709. Revised: February 2013

Last reviewed on RxList: 3/19/2013
This monograph has been modified to include the generic and brand name in many instances.

A A A

Malarone - User Reviews

Malarone User Reviews

Now you can gain knowledge and insight about a drug treatment with Patient Discussions.

Here is a collection of user reviews for the medication Malarone sorted by most helpful. Patient Discussions FAQs

Report Problems to the Food and Drug Administration

 

You are encouraged to report negative side effects of prescription drugs to the FDA. Visit the FDA MedWatch website or call 1-800-FDA-1088.


Women's Health

Find out what women really need.

Related Supplements
advertisement
advertisement
Use Pill Finder Find it Now See Interactions

Pill Identifier on RxList

  • quick, easy,
    pill identification

Find a Local Pharmacy

  • including 24 hour, pharmacies

Interaction Checker

  • Check potential drug interactions
Search the Medical Dictionary for Health Definitions & Medical Abbreviations